Mrs. L. Anne Mazel, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10141 Us 59 Hwy Ste E1, Wharton, TX 77488 Phone: 979-358-9410 Fax: 979-358-9411 |
Susan F Ringel, APRN FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 2022 Regional Medical Dr, Suite 1319, Wharton, TX 77488 Phone: 979-282-2786 Fax: 979-282-2830 |
Esther Saugar Velasco Vesely, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2112 Regional Medical Dr Ste 1319, Wharton, TX 77488 Phone: 713-486-7630 Fax: 713-500-0858 |
Constance Priscilla Bowie, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 416 N Alabama Rd, Wharton, TX 77488 Phone: 979-282-6151 |
Taryn Leigh Teykl, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700 |
Mrs. Maureen K. Voulgaris, RNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700 Fax: 979-532-6790 |
Peggy Lee Avendano, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 911 E Boling Hwy, Wharton, TX 77488 Phone: 979-545-5510 |
Debra Hulsey, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1403 Valhalla Dr, Wharton, TX 77488 Phone: 979-532-2000 |
Mrs. Janie Martinez Avila, RN, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700 Fax: 979-532-6797 |
Mr. Charles W. Mcgee, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 416 N Alabama Rd, Wharton, TX 77488 Phone: 979-282-6151 Fax: 832-930-4586 |
Alice Marie Heard, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 1400 N Fulton St, Wharton, TX 77488 Phone: 979-257-5044 |
News Archive
A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center have found.
Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A function enhances a cellular stress response pathway that promotes survival of cancer cells, which become sensitive to pharmacological inhibition of this pathway. These findings were published online in Cancer Research, a journal of the American Association for Cancer Research, and point to a new therapeutic opportunity for this type of ovarian cancer for which new solutions are urgently needed.
When weighing in potentially explosive environments, it is important that equipment is safe, compliant and able to be handled efficiently. METTLER TOLEDO helps meet hazardous-area regulations and maintain the level of accuracy and flexibility required by processes with intrinsically safe ICS4_6x combi bench scales.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
› Verified 4 days ago